• Home
• Medicine ↘
  • Medical Uses
  • Side Effects ↘
  • Studies and Case Reports
• Science ↘
  • Definitions
  • List of Clinical Studies
  • Database of Clinical Studies
  • Clinical Studies 2005-2009
  • Clinical Studies 2010-2014
• Laws and Politics ↘
  • Overview English
  • Austria/Österreich
  • Belgium
  • Canada
  • Chile
  • Croatia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany / Deutschland
  • Israel
  • Italy / Italia
  • Japan
  • Luxembourg
  • New Zealand
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • The Netherlands / Nederland
  • UK
  • United States of America
• Partners worldwide ↘
  • Partner organisations
• Archive ↘
  • IACM-Bulletin
• FAQ
• British Association ↘
  • Legal Status
  • Sativex
  • Cannabinoids
• Links
• About us ↘
  • Introduction
  • Board of Directors
  • Statutes
• Membership
• Donation
• Imprint
• Data Protection Regulation

Journals

• Newsletter
  • IACM-Bulletin
  • Subscribe
• Journal
  • CCR (current)
  • Cannabinoids (former)
  • Therapeutics (former)
• Conference & Webinars
  • Webinars & Anniversary Online Meeting (both free)
  • Former
  • ICRS
• Language
  • English
  • Deutsch
  • Français
  • Nederlands
  • Español
  • Português
  • Italiano

You are here: Home > About us > Introduction

Introduction

The International Association for Cannabinoid Medicines (IACM) was founded in March 2000. The aim of the association is to advance knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics especially with regard to their therapeutic potential. The mission is achieved in particular through the following actions:

• Support for research into cannabis products and the endocannabinoid system;
• Promotion of exchange of information between researchers, health care practitioners, patients and the public;
• Preparation and dissemination of reliable information on the pharmacology, toxicology and therapeutic potential of cannabis and modulators of the endocannabinoid system;
• Monitoring and documentation of national and international developments with respect to cannabinoid therapeutics;
• Co-operation with other organisations and associations sharing the mission and goals of the IACM

The IACM declares that it is the right of doctors to be able to discuss the medicinal use of cannabis with their patients.

Membership

There are regular and associate members. Regular members elect the board of directors consisting of up to ten members and decide on the guidelines of the association. Associate members elect up to two patient representatives The patient representatives may participate with equal rights in the meetings of the Board of Directors. The complete statutory articles of the IACM can be downloaded here as a pdf file.

Publications

Members receive the newsletter of IACM (IACM-News). The IACM Bulletin is published in several languages on the internet. Free subscription with the online-form.